190 related articles for article (PubMed ID: 14175)
1. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
Jakobs KH; Saur W; Schultz G
J Cyclic Nucleotide Res; 1976; 2(6):381-92. PubMed ID: 14175
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
Alexander RW; Cooper B; Handin RI
J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
5. Activation of adenylate cyclase from purified platelet membranes by prostaglandin E1 and its inhibition by L-epinephrine: mechanistic effects.
Steer ML; Braun S; Lester HA; Levitzki A
J Cyclic Nucleotide Res; 1982; 8(5):309-22. PubMed ID: 7182416
[TBL] [Abstract][Full Text] [Related]
6. The alpha adrenergic response of Down's syndrome platelets.
Sheppard JR; Schumacher W; White JG; Jakobs KH; Schultz G
J Pharmacol Exp Ther; 1983 Jun; 225(3):584-8. PubMed ID: 6306212
[TBL] [Abstract][Full Text] [Related]
7. [The adenylate cyclase system of human platelets].
Ferry N; Adnot S; Insel PA; Hanoune J
Nouv Rev Fr Hematol (1978); 1983; 25(6):343-53. PubMed ID: 6141550
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
Watanabe Y; Jakobs KH
Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
[TBL] [Abstract][Full Text] [Related]
9. The effect of alpha and beta adrenergic receptor stimulation on the adenylate cyclase activity of human adipocytes.
Burns TW; Langley PE
J Cyclic Nucleotide Res; 1975; 1(5):321-8. PubMed ID: 1225939
[TBL] [Abstract][Full Text] [Related]
10. Receptors, adenylate cyclase, depression, and lithium.
Belmaker RH
Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
[TBL] [Abstract][Full Text] [Related]
11. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adenylate cyclase activity in bovine and human corneal epithelium.
Walkenbach RJ; LeGrand RD; Barr RE
Invest Ophthalmol Vis Sci; 1980 Sep; 19(9):1080-6. PubMed ID: 6106005
[TBL] [Abstract][Full Text] [Related]
13. Metal and metal-ATP interactions with human platelet adenylate cyclase: effects of alpha adrenergic inhibition.
Jakobs KH; Saur W; Schultz G
Mol Pharmacol; 1978 Nov; 14(6):1073-8. PubMed ID: 32476
[No Abstract] [Full Text] [Related]
14. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the stimulatory effect of adrenaline and prostaglandin E1 on the human fat cell adenylate cyclase by adenosine.
Kather H; Simon B
Horm Metab Res; 1980 Apr; 12(4):169-72. PubMed ID: 7390397
[TBL] [Abstract][Full Text] [Related]
16. Alpha-adrenergic inhibition of renal cortical adenylate cyclase.
Woodcock EA; Johnston CI; Olsson CA
J Cyclic Nucleotide Res; 1980; 6(4):261-9. PubMed ID: 6110680
[TBL] [Abstract][Full Text] [Related]
17. Hormone-sensitive fat cell adenylate cyclase in the rat. Influences of growth, cell size, and aging.
Cooper B; Gregerman RI
J Clin Invest; 1976 Jan; 57(1):161-8. PubMed ID: 173740
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
19. Interactions of agonists with platelet alpha 2-adrenergic receptors.
Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
Johnson JA; Goka TJ; Clark RB
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
